TORONTO, Dec. 13, 2017 -- ECN Capital Corp. (TSX:ECN) (“ECN Capital” or “the Company”), one of North America’s leading finance companies, today announced that it will host an analyst briefing regarding the 2018 forecast and corporate developments.
The briefing will be held at 8:00 AM (ET) on Thursday December 14, 2017 and can be accessed as follows:
| Webcast | http://services.choruscall.ca/links/ecncapitalcorp201712_2018guidance.html |
| Toll-free dial in | North America 1-800-319-8560 International http://services.choruscall.ca/public/accessnumbers.html Passcode 83408 |
| Presentation slides | http://ecncapitalcorp.com/investors/presentations |
The webcast will be available until March 14, 2018. A recording of the conference call will also be available until January 14, 2018 by dialing 1-855-669-9658 in North America and entering the passcode 1956.
About ECN Capital Corp.
With total owned and managed assets of more than $4.7 billion, ECN Capital Corp. (TSX:ECN) is one of North America's leading finance companies. ECN Capital operates in four verticals: Home Improvement Finance, Commercial & Vendor Finance, Rail Finance and Aviation Finance.
Contact
| John Wimsatt Senior Vice President, Corporate Development and Investor Relations 647-649-4634 [email protected] |


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Amazon Explores AI Content Marketplace With Media Publishers
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



